Dave Keating

Pelican Life Sciences has emerged from the shadows with $100 million in financing from Grotech Capital and Ferrer Freeman.

The Washington, DC-based firm will sell its share of the US bottling unit to joint venture partner, Cadbury Schweppes.

A year and a half after the former Democratic Senate Majority Leader was voted out of office, Apollo Investment Corp. welcomes him to their board of directors.

Amit Yoran, the head of In-Q-Tel, has quit after just four months on the job, citing personal reasons.

The historically reclusive firm peeks out from behind the curtain with a new web space.

Russell Read will take the helm at the largest public pension fund in the US on June first.

The Omaha, Nebraska-based firm, expecting increased demand for natural gas, will take a 50 percent ownership in a company building a gas storage facility.

Leonard Schaeffer and his team from WellPoint will advise the firm on opportunities in the healthcare sector, having taken America’s largest benefits provider from ‘mess’ to ‘powerhouse’.

Madrona’s recent closing of a $167 million fund is only the latest in a flurry of VC activity in Seattle. Is the Pacific Northwest emerging as a VC powerhouse? By Dave Keating.

Bucking some predictions, the Seattle-based firm has closed a $167 million fund to invest in technology start-ups.